// App-Quantinova.ai

: Multiple Myeloma Treatment Is Associated with Enhanced Platelet Reactivity

Researchers

Presenter

  • Jonathan Gibbins

Principal Investigators

  • Rekha Rana

  • Dalia Khan

  • Susie Shapiro

  • Henri Grech

  • Karthik Ramasamy

Medical Centers

  • Inst. for Cardiovascular and Metabolic Research, School of BIological Sciences, Inst. for Cardiovascular and Metabolic Research University of Reading, Reading, United Kingdom

  • Institute For Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, GBR

  • NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford

  • Royal Berkshire NHS Foundation Trust, Reading, United Kingdom

  • Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Oxford ,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Obstetrics/Gynecology

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Monoclonal gammopathy

  • Smoldering myeloma

  • Multiple Myeloma

  • Venous thrombosis

  • Twin-reversed arterial perfusion

Biomarkers

  • Cluster of Differentiation 31

  • Integrin subunit beta 3

  • Triiodothyronine receptor auxiliary protein

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Epinephrine

  • Adrenaclick

  • Bortezomib

  • Fibrinogen (IV)

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved